| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | NEUTRAL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 6.62▲ | 6.62▲ | 6.62▲ | 6.36▲ | 6.68▼ |
| MA10 | 6.56▲ | 6.55▲ | 6.55▲ | 6.18▲ | 6.84▼ |
| MA20 | 6.45▲ | 6.32▲ | 6.32▲ | 6.68▼ | 9.93▼ |
| MA50 | 6.17▲ | 6.12▲ | 6.10▲ | 7.11▼ | N/A |
| MA100 | 6.07▲ | 6.54▲ | 6.76▼ | 10.97▼ | N/A |
| MA200 | 6.75▼ | 7.08▼ | 6.96▼ | N/A | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.012▲ | 0.038▲ | 0.044▲ | N/A | N/A |
| RSI | 64.590▲ | 72.278▲ | 69.297▲ | N/A | N/A |
| STOCH | 84.549▲ | 82.137▲ | 82.137▲ | 55.925 | 25.787 |
| WILL %R | 0.000▲ | 0.000▲ | 0.000▲ | -53.774 | -92.138▼ |
| CCI | 152.985▲ | 125.992▲ | 125.992▲ | 105.592▲ | -59.588 |
|
Tuesday, February 19, 2019 06:26 AM
WARREN, N.J., Feb. 19, 2019 /PRNewswire/ -- Aquestive Therapeutics, Inc. (NASDAQ: AQST), a specialty pharmaceutical company focused on developing and commercializing differentiated products to solve t...
|
|
Tuesday, February 12, 2019 09:44 AM
The following slide deck was published by Aquestive Therapeutics in conjunction with this event. 123 Click to enlarge Notes:
|
|
Friday, February 08, 2019 06:00 AM
WARREN, N.J., Feb. 8, 2019 /PRNewswire/ -- Aquestive Therapeutics, Inc. (NASDAQ: AQST), a specialty pharmaceutical company, focused on developing and commercializing differentiated products to ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 19/02/19 | 6.67 | 7.07 | 6.40 | 6.58 | 70,240 |
| 15/02/19 | 6.42 | 6.75 | 6.36 | 6.66 | 70,991 |
| 14/02/19 | 6.12 | 6.7402 | 6.025 | 6.41 | 105,869 |
| 13/02/19 | 6.04 | 6.19 | 6.03 | 6.13 | 44,246 |
| 12/02/19 | 5.97 | 6.1153 | 5.85 | 6.03 | 34,286 |
| 11/02/19 | 6.18 | 6.25 | 5.85 | 5.90 | 79,853 |
| 08/02/19 | 5.97 | 6.32 | 5.9396 | 6.19 | 33,642 |
| 07/02/19 | 5.90 | 6.10 | 5.81 | 6.02 | 49,964 |
| 06/02/19 | 6.00 | 6.15 | 5.91 | 5.95 | 71,675 |
| 05/02/19 | 5.65 | 6.39 | 5.64 | 5.98 | 130,096 |
|
|
||||
|
|
||||
|
|
||||
|
|